Sponsor Pipeline

Wave Life Sciences Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
0
Recruiting
1
Disease Areas
Active Trials by Phase
Phase 2
1
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07209332 Open-Label Extension Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy Duchenne Muscular Dystrophy Enrolling by Invitation
Phase 1/2
NCT06405633 A Phase 1b/2a, Open-label Single Ascending Doses and Multiple Ascending Doses Study in… Alpha-1 Antitrypsin Deficiency Active, Not Recruiting
Disease Areas
Duchenne Muscular Dystrophy (1)
Get alerts when Wave Life Sciences Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free